Improving Characterization of Calcifications With Contrast-Enhanced Mammography



Status:Not yet recruiting
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:30 - Any
Updated:1/19/2019
Start Date:February 28, 2019
End Date:February 28, 2021
Contact:Matthew Covington, M.D.
Email:covington@wustl.edu
Phone:314-747-7696

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study protocol is to assess whether contrast-enhanced mammography (CEM)
will increase the accuracy of characterization of microcalcifications detected on screening
mammography prior to biopsy as either benign, high risk, or malignant.


Inclusion Criteria:

- Women with calcifications detected on screening mammogram for which biopsy is
recommended following characterization on diagnostic mammography.

- At least 30 years of age.

- Able to understand and willing to sign an IRB-approved written informed consent
document

- GFR ≥ 30 mL/min/1.73 m2

Exclusion Criteria:

- Pregnant

- Prior history of allergy or hypersensitivity reaction to iodinated contrast

- History of chronic renal disease (including dialysis, kidney transplant, single
kidney, renal cancer, or renal surgery)

- Patients with known thyroid disorders, pheochromocytoma or sickle cell anemia
We found this trial at
1
site
Washington University School of Medicine
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials